Presented on November 22, 2024.

Lupin Neurosciences presents Mexiletine program myotonic dystrophy type 1 (DM1)-01 program. Click here to learn more about Lupin Neurosciences.

Presenters include:

• Mariska van Aswegen, Vice President – Neurology, EMEA
• Claus J. Jepsen, President, Global Specialty
• Alla Zozulya Weidenfeller, PhD, Senior Medical Director, Head of Medical Affairs and Clinical Development

MDF Resources referenced in the Video:

• Toolkits & Publications
• MDF Support Groups
• Digital Academy
• Calendar of Events
• DM Drug Development Pipeline
• Myotonic Dystrophy Family Registry (MDFR)
• 2025 MDF Annual Conference
• Sign up for My Dispatch, our monthly e-newsletter

About Meet the Myotonic Dystrophy Drug Developers

Biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to find all our upcoming Meet the DM Drug Developers dates!